🦠 Chapter 242 · Moraxella catarrhalis

Nelson Textbook of Pediatrics 22nd Edition | Gram-negative diplococcus, β-lactamase producer (amoxicillin resistant), normal respiratory flora, causes otitis media, sinusitis, lower respiratory tract infections in COPD. Treatment: amoxicillin-clavulanate, cephalosporins, macrolides, TMP-SMX.

🌐 paeds.online — Pakistan's Pediatric Platform

📋 30 Clinical Scenarios — Moraxella catarrhalis (Nelson Ch 242)

📇 High‑Yield Review Cards (Moraxella catarrhalis)

🩺 Moraxella catarrhalis Clinical Scenarios

Select a scenario for diagnosis and management.

📋 Stepwise Management of M. catarrhalis Infections

    📊 Antibiotic Susceptibility of M. catarrhalis

    Antibiotic ClassActivityNotes
    Penicillins (amoxicillin, ampicillin)Resistant (>90% produce β-lactamase)Do not use alone. Use amoxicillin-clavulanate.
    Cephalosporins (oral, parenteral)Susceptible (first, second, third generation)Cefdinir, cefpodoxime, ceftriaxone effective.
    Macrolides (azithromycin, clarithromycin)Susceptible (but increasing resistance reported)Azithromycin often used for otitis media/pneumonia.
    Fluoroquinolones (ciprofloxacin, levofloxacin)Susceptible (but reserve for appropriate indications)Effective, but not first-line in children.
    TMP-SMX (trimethoprim-sulfamethoxazole)

    ⚡ Reflex Prompts — Moraxella Decisions

    📖 Summary: Moraxella catarrhalis — Nelson Ch 242